Ann Arbor, MI, United States of America

Stuart James Decker

This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stuart James Decker. Retrieved from https://idiyas.com/inventor/stuart-james-decker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stuart James Decker and His Patent on SH-2 Binding Antagonists.

Introduction

Stuart James Decker is an inventor associated with Ann Arbor, Michigan, and Warner-Lambert Company. His patent work concerns compounds intended to interfere with protein tyrosine kinase binding and their potential use in treating a range of diseases.

Latest Patents

Decker is credited with 1 patent, titled “Substituted Imidazolinyl-Imidazolines as Antagonists of SH-2 Binding.” The patent describes methods and pharmaceutical compositions involving specified imidazoline compounds, derivatives, and salts. These compounds are presented as antagonists of the association between a protein tyrosine kinase and a substrate regulatory protein. The disclosed potential applications include proliferative, viral, inflammatory, allergic, and cardiovascular diseases, as well as restenosis.

Career Highlights

Decker’s listed patent reflects research into chemical compounds and their possible therapeutic applications. The patent identifies Warner-Lambert Company as his associated company.

Collaborations

The provided information lists James Marino Hamby and Alan Robert Saltiel as Decker’s coworkers. It does not specify their roles in the patent or the nature of their collaboration.

Conclusion

Stuart James Decker’s recorded patent focuses on substituted imidazolinyl-imidazolines designed to antagonize SH-2 binding, with proposed applications across several disease areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…